Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) Return on Sales (2016 - 2025)

Historic Return on Sales for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to 0.11%.

  • National Healthcare's Return on Sales fell 200.0% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.08% for FY2024, which is 200.0% up from last year.
  • Latest data reveals that National Healthcare reported Return on Sales of 0.11% as of Q3 2025, which was down 200.0% from 0.06% recorded in Q2 2025.
  • National Healthcare's 5-year Return on Sales high stood at 0.4% for Q2 2021, and its period low was 0.01% during Q3 2021.
  • Its 5-year average for Return on Sales is 0.07%, with a median of 0.06% in 2023.
  • Per our database at Business Quant, National Healthcare's Return on Sales soared by 2900bps in 2021 and then tumbled by -3900bps in 2022.
  • Quarter analysis of 5 years shows National Healthcare's Return on Sales stood at 0.04% in 2021, then plummeted by -44bps to 0.02% in 2022, then skyrocketed by 341bps to 0.09% in 2023, then tumbled by -82bps to 0.02% in 2024, then skyrocketed by 557bps to 0.11% in 2025.
  • Its last three reported values are 0.11% in Q3 2025, 0.06% for Q2 2025, and 0.09% during Q1 2025.